Company profile
Afortiori Development Ltd
Bot Verification
Afortiori Development Ltd is a UK company with status active founded in 2017 based in North East England.
Latest accounts
Financial period: 1 Jan 2024 to 31 Dec 2024
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzQ0MDI2MDI3M2FkaXF6a2N4
Published 21 Oct 2024 08:07
Change Person Director Company With Change Date
OfficersCH01 | Transaction MzQzOTU0MzQ0MWFkaXF6a2N4
Published 16 Oct 2024 10:48
Change To A Person With Significant Control
Persons-with-significant-controlPSC04 | Transaction MzQzOTU0MzQzNGFkaXF6a2N4
Published 16 Oct 2024 10:47
Change Person Director Company With Change Date
OfficersCH01 | Transaction MzQzOTU0MzQ0M2FkaXF6a2N4
Published 15 Oct 2024 10:38
Change To A Person With Significant Control
Persons-with-significant-controlPSC04 | Transaction MzQzOTU0MzQzNmFkaXF6a2N4
Published 15 Oct 2024 10:38
Change Person Director Company With Change Date
OfficersCH01 | Transaction MzQzODcwMDEzOWFkaXF6a2N4
Published 08 Oct 2024 08:18
Change To A Person With Significant Control
Persons-with-significant-controlPSC04 | Transaction MzQzODcwMDA2MGFkaXF6a2N4
Published 08 Oct 2024 08:17
Accounts With Accounts Type Unaudited Abridged
Accounts AnalysedAA | Transaction MzQzMTYxOTU2MGFkaXF6a2N4
Published 08 Aug 2024 12:40
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
First-in- Human (FIH) Trials of a Novel Bioresorbable Coronary Scaffold (ArterioSorb™)
1 Jul 2019 to 30 Sep 2022
Arterius Ltd, a UK SME based in Leeds, and Afortiori Ltd, a UK based SME are planning to initiate first human trials of it's novel bioresorbable scaffold (stent) (BRS), ArterioSorb-BRS in 2019, having passed pre-clinical evaluations with an excellent data due to the support of the Innovate UK grants. ArterioSorb-BRS is designed to treat coronary artery di...